Medtronic PLC
F:2M6

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
F:2M6
Watchlist
Price: 85.82 EUR 2.06% Market Closed
Market Cap: 110B EUR

Net Margin

13.7%
Current
Improving
by 1%
vs 3-y average of 12.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.7%
=
Net Income
$4.8B
/
Revenue
$34.8B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.7%
=
Net Income
€4.8B
/
Revenue
$34.8B

Peer Comparison

Country Company Market Cap Net
Margin
IE
Medtronic PLC
NYSE:MDT
130.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
191.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
138.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.2B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.6B USD
Loading...
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
17.4B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.2B USD
Loading...
US
Resmed Inc
NYSE:RMD
38B USD
Loading...

Market Distribution

Higher than 80% of companies in Ireland
Percentile
80th
Based on 314 companies
80th percentile
13.7%
Low
-6 913.1% — 0%
Typical Range
0% — 10.2%
High
10.2% — 197.7%
Distribution Statistics
Ireland
Min -6 913.1%
30th Percentile 0%
Median 3.1%
70th Percentile 10.2%
Max 197.7%

Medtronic PLC
Glance View

In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.

2M6 Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
13.7%
=
Net Income
$4.8B
/
Revenue
$34.8B
What is Medtronic PLC's current Net Margin?

The current Net Margin for Medtronic PLC is 13.7%, which is above its 3-year median of 12.8%.

How has Net Margin changed over time?

Over the last 3 years, Medtronic PLC’s Net Margin has decreased from 14% to 13.7%. During this period, it reached a low of 11.4% on Apr 26, 2024 and a high of 14% on Oct 28, 2022.

Back to Top